ArticleJournal of cancer research and clinical oncology2020

Prostaglandin E2 receptor 3 (EP3) signaling promotes migration of cervical cancer via urokinase-type plasminogen activator receptor (uPAR).

Yao Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.